CYCLIC AMINE SUBSTITUTED HETEROCYCLIC CETP INHIBITORS

摘要

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and may be useful for raising HDL-cholesterol and reducing LDL-cholesterol in human patients and for treating or preventing atherosclerosis. Further, the pharmaceutical compositions of the present invention can include a pharmaceutically acceptable carrier and optionally other therapeutic ingredients.